Skip to content

Opening book details…

About this Medicine article

A phase II trial of neoadjuvant doxorubicin plus cyclophosphamide followed by lapatinib plus docetaxel sequential with adjuvant trastuzumab for treatment of early HER2 positive breast cancers by Vidal, Gregory A.; Vontela, Namratha; Chen, Mary; Ryder, Julie M.; Sheth, Struti; Guardino, Ellie is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Vidal, Gregory A.; Vontela, Namratha; Chen, Mary; Ryder, Julie M.; Sheth, Struti; Guardino, Ellie
Publisher
Sciedu Press (ISSN 1925-4067)
Published
2017
Field
Medicine (Health Sciences)

More by Vidal, Gregory A.; Vontela, Namratha; Chen, Mary; Ryder, Julie M.; Sheth, Struti; Guardino, Ellie

Browse all works by Vidal, Gregory A.; Vontela, Namratha; Chen, Mary; Ryder, Julie M.; Sheth, Struti; Guardino, Ellie